TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
TELA Bio, a NASDAQ-listed medical technology company specializing in soft-tissue reconstruction solutions, announced its participation and management presentation at the upcoming Canaccord Genuity 46th Annual Growth Conference scheduled for August 12, 2026.